Results CALENDAR
W
T
F
S
S
M
T
W
T
F
S
S
M
T
W
T
F
S
S
M
T
W
T
F
S
S
M
T
W
T
F
May 2013 12345678910111213141516171819202122232425262728293031
India Earnings >> Pre Result Estimates
  You are here : Home » Biocon » Pre Result Estimates
Biocon
* Last Announced: Jun 07 Result
 Pre Result Estimates
1234
Biocon Q1 PAT seen up 36% at Rs 78 cr       22nd-Jul-2010
Biocon is to announce its first quarter results FY11. According to CNBC-TV18's estimates, Q1 revenues are seen up 26.3% to Rs 626 crore versus Rs 495.9 crore.
Biocon Jun qtr PAT seen up at Rs 69.8 cr: M Oswal       8th-Jul-2010
Motilal Oswal has come out with its earning estimates on Pharmaceuticals sector for the quarter ended June 2010.
Biocon Q4 PAT seen up at Rs 76.2 cr       28th-Apr-2010
Biocon is to announce its fourth quarter results. According to CNBC-TV18's estiamtes, the company's Q4FY10 revenues are seen up 31% to Rs 615.9 crore versus Rs 468 crore, year-on-year.
Biocon Q3 PAT seen up at Rs 79.52 cr       20th-Jan-2010
Biocon is to declare its third quarter results. According to CNBC-TV18 estimates, the company's revenues are seen up 27.9% to Rs 557.9 crore versus Rs 436.2 crore.
Biocon Q2 net profit seen up at Rs 60 cr       21st-Oct-2009
Biocon is to announce its second quarter results. According to CNBC-TV18 estimates, the company’s Q2 net sales are seen up 18% at Rs 520 crore versus Rs 439 crore.
Biocon Sept qtr PAT seen up 128.3% to Rs 57.5 cr: M Oswal       10th-Oct-2009
Motilal Oswal has come out with its earning estimates for Pharmaceutical sector for the quarter ended September 2009. According to the research firm, Biocon's September quarter net sales are expected to go up by 19% to Rs 526.6 crore on YoY basis.
Biocon Q1 net loss seen at Rs 89.6 cr: IIFL       9th-Jul-2009
IIFL has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, Biocon's June quarter sales is expected to go up by 75.2% to Rs 462.4 crore on YoY basis.
Biocon Q1 PAT seen at Rs 76 cr: KRChoksey       7th-Jul-2009
KRChoksey has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, Biocon's June quarter sales are expected to go up by 72% to Rs 454 crore on YoY basis.
Biocon Q1 PAT seen up at Rs 66.5 cr: Motilal Oswal       4th-Jul-2009
Motilal Oswal has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, Biocon's June quarter sales are expected to go up by 82.2% to Rs 480.7 crore on YoY basis.
Biocon Q1 net profit seen up at Rs 70.5 cr: Religare       4th-Jul-2009
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, Biocon's June quarter sales are expected to go up by 73.3% to Rs 457,4 crore on YoY basis.
Biocon Q4 net profit seen down 34% at Rs 43 cr       27th-Apr-2009
Biocon is to announce its fourth quarter results. According to CNBC-TV18 estimates, the company’s Q4FY09 consolidated net sales are seen up 74% at Rs 463 crore versus Rs 266.63 crore.
Biocon Mar qtr net profit seen at Rs 27.27 cr: Rel Money       21st-Apr-2009
Reliance Money has come out with its earning estimates on the Pharmaceuticals Sector for the quarter ended March 2009. According to the research firm, Biocon's March quarter sales are expected to go up by 72.9% to Rs 460.97 crore on YoY basis.
Biocon Q4 PAT seen down 34% at Rs 43 cr       16th-Apr-2009
Biocon is to declare its fourth quarter results. According to CNBC-TV18 estimates, the company’s Q4 FY09 consolidated net sales are seen up 74% at Rs 463 crore versus Rs 266.63 crore.
Biocon Mar qtr PAT seen up 13.8% at Rs 74.3 cr: Religare       11th-Apr-2009
Religare Hichens Harrison has come out with its earning estimates on the Pharmaceuticals sector for the quarter ended March 2009. According to the research firm, Biocon's March quarter sales are expected to go up by 66.5% to Rs 443.8 crore on YoY basis.
Biocon Mar qtr PAT seen down 35% to Rs 42 cr: IIFL       9th-Apr-2009
IIFL has come out with its earning estimates on the Pharmaceutical sector for the quarter ended March 2009. According to the research firm, Biocon's March quarter sales are expected to go up by 63% to Rs 434.1 crore on YoY basis.

Results so Far

Search

 Best Performers
 Worst Performers
 Positive Turnarounds
 Negative Turnarounds
 Latest Results
 Sector Performance
Most Visited
 Results Calendar
 Board Meetings
 Book Closures
 Dividend Calendar
 Brokerage Reports
 FII Comments
 Pre Result Estimates
 Results At A Glance
 Interview With Management
 CNBC TV18 Live Video
Results at a glance
AstraZeneca Q4 net loss at Rs 19 cr... May 22
Prestige Estates Q4 net jumps more ... May 22
JSW Ispat reports Rs 159.33 cr net ... May 21
more
Press Releases
Pre Result Estimates
India Cements Q4 PAT seen down 26% ... May 20
Tata Steel profit may lag estimates... May 20
Here's what to expect from Adani En... May 20
more
Management Talk
Insatiable demand for data has driv... May 21 Watch Video
Key focus on profitability, not gro... May 21 Watch Video
Yet to get clarity on power price h... May 21 Watch Video
more
FII Comments
more
Analyst View
Antique downgrades ITC to 'hold' on... May 20
Asset quality main concern for PSU ... May 13 Watch Video
Check out Tulsian's hit and misses ... May 11 Watch Video
more
CNBC TV18 View
Indian pharmas gain on N America bo... May 09 Watch Video
HDFC Bank Q4 NII seen up 17% to Rs ... Apr 23 Watch Video
more
Brokerage Reports
Buy Oberoi Realty; target of Rs 295... May 21
Accumulate Bajaj Auto; target of Rs... May 21
Hold Bajaj Auto: Ventura... May 21
more
Press Conferences
Excise duty, higher input costs hur... May 21 Watch Video
We will refocus on growth in 2013-1... May 13 Watch Video
Bharti Airtel Q4: Pricing stability... May 02
more
Analyst Concalls
more
Source : Dion Global Solutions Limited
Site Map  |  About us  |  Contact us  |  Advertise  |  Feedback  |  Disclaimer  |  Privacy Policy  |  Terms of Use
copyright © 2008. IndiaEarnings.com
Results
Results Till Now
Press Releases
Estimates
CEO CALL
Mgmt Interviews
Press Conference
Conference Calls
 
ANALYSIS
CNBC-TV18 View
Brokerage Calls
Analyst Views
NEWS